Blog: VYANT BIO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) – Marketscreener.com

Item 7.01 Regulation FD.

On November 16, 2022, Vyant Bio, Inc. (the “Company”) issued a press release
announcing that the Company made two platform and poster presentations during
the Rett Nanosymposium at Neuroscience 2022, hosted by the Society for
Neuroscience, which was held November 12th-16th at the San Diego Convention
Center. A copy of the press release is attached hereto as Exhibit 99.1.

The information in this Current Report on Form 8-K under Item 7.01, including
the information contained in Exhibit 99.1, is being furnished to the Securities
and Exchange Commission, and shall not be deemed to be “filed” for the purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”), or otherwise subject to the liabilities of that section, and shall not be
deemed to be incorporated by reference into any filing under the Securities Act
of 1933, as amended, or the Exchange Act, except as shall be expressly set forth
by a specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits


As described above, the following exhibits are furnished as part of this report:

Exhibit No. Description

99.1            Press Release issued by Vyant Bio, Inc., dated November 16, 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s